VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $232,000 | -5.3% | 10,000 | -35.1% | 0.01% | -36.4% |
| Q1 2018 | $245,000 | -99.3% | 15,400 | -91.8% | 0.02% | -98.5% |
| Q3 2015 | $33,321,000 | +3.6% | 186,798 | +29.1% | 1.44% | -18.7% |
| Q2 2015 | $32,151,000 | -23.3% | 144,727 | -31.4% | 1.77% | +1.1% |
| Q1 2015 | $41,896,000 | +413.5% | 210,934 | +239.2% | 1.75% | +391.3% |
| Q3 2014 | $8,159,000 | -28.1% | 62,190 | -30.9% | 0.36% | -31.2% |
| Q2 2014 | $11,351,000 | -17.8% | 90,000 | -23.5% | 0.52% | +2.4% |
| Q4 2013 | $13,816,000 | +12.5% | 117,681 | 0.0% | 0.51% | +1.8% |
| Q3 2013 | $12,278,000 | +21.2% | 117,681 | 0.0% | 0.50% | +21.8% |
| Q2 2013 | $10,130,000 | – | 117,681 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |